et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 23, 7594–7603 (2005). Article PubMed Google Scholar Pang, W. W. et al. Hematopoietic stem cell and progenitor cell mechanisms ...
Higher risk patients have short life expectancy with chemotherapy, and will generally benefit from the HSCT. Risk for NRM should be carefully eva-luated, and relies on functional age assessment related to general performance status and comorbidities. When a patient has an indication of HSCT, a ...